The short answer. For nearly every reader, retail cash-value life insurance — whole life, universal life, variable life, variable universal life, indexed universal life — is the wrong product. Buy level-premium term to cover the death-benefit need, invest the difference in a tax-managed taxable portfolio (section “The Structural Obsolescence of Mutual Funds in Taxable Accounts”) and the tax-advantaged accounts you already have access to, and skip the cash-value pitch entirely. The three legitimate exceptions are estate-tax funding via a second-to-die policy in an ILIT (section “Second-to-die Policy”), intra-family premium financing in narrow estate-equalization contexts, and Private Placement Life Insurance for ultra-large balance sheets (section “Private Placement Life Insurance (PPLI)”). Everything else is an agent-driven sale that recovers its commission and load by underperforming the buy-term-and-invest-the-difference benchmark for the first ten to fifteen policy years.
Why the math runs against you. A retail cash-value policy bundles three things: a death benefit (priced as if it were term), a savings account (the cash value), and a sales and administrative load. The agent’s first-year commission typically runs 50%–100% of the first year’s premium, recovered over many years out of the spread between what the insurer earns on your premium and what it credits to your cash value. The death-benefit cost of insurance (COI) escalates with age and is debited from the cash value every month. The illustrations the agent shows you assume a constant credited rate (whole life) or a cap-and-floor projection (IUL) that the carrier can and does revise downward over the life of the policy. The promised tax treatment is real, but the load you pay to get it dwarfs the tax benefit at all but the very largest commitment sizes. The Consumer Federation of America’s recurring rate-of-return analyses have shown internal returns on retail cash-value policies in the 1%–4% range over a 20-year hold, before adjusting for the death-benefit cost. Term plus a tax-managed portfolio underperforms only in the case the insured dies young — exactly the case term alone was designed to cover.
The §7702 wrapper. Under IRC §7702, “Life insurance contract defined”, a US life insurance contract earns its tax-preferred treatment (tax-deferred inside growth, tax-free death benefit) only if it passes either the Cash Value Accumulation Test (CVAT) or the Guideline Premium and Corridor Test (GPT). Both tests are anti-abuse rules to prevent investors from dressing up an investment account as “insurance.” If a policy accepts premiums above the IRC §7702 caps, it becomes a Modified Endowment Contract (MEC) under IRC §7702A and loses the tax-free borrowing feature — distributions during life are taxed as ordinary income to the extent of gain, and additional 10% penalty applies before age 591/2. Forced MEC status is the trap behind some single-premium designs; check policy projections for the seven-pay test before signing.
Fixed premium, fixed death benefit, fixed (low) credited rate on cash value. Conservative and predictable. Mutual carriers (Northwestern Mutual, MassMutual, New York Life, Guardian) pay annual dividends that can buy paid-up additions; the dividend is not contractual. Use case: forced-savings personality types who would not otherwise invest the difference, and second-to-die ILIT structures. Otherwise skip.
WL with premiums paid over 10, 20, or until age 65, then paid-up. Higher annual premium, smaller window of payment obligation. Same math; same prescription.
Flexible premium, flexible death benefit, credited rate moves with the carrier’s portfolio. The 1980s lesson: policies sold on 12%–15% projected rates blew up when actual rates fell and policyholders faced surprise premium increases or policy lapse. Re-illustrate annually; the current credited rate is what matters, not the policy-issue projection.
Cash value invested in sub-accounts that look like mutual funds, wrapped in the IRC §7702 tax shell, registered as securities (so the salesperson must hold a Series 6 or 7 plus the insurance license). Headline appeal: tax-deferred equity exposure. Real result: sub-account expense ratios run 70–120 basis points above retail mutual funds for similar mandates, plus M&E (mortality and expense risk) charges of 50–90 basis points, plus the COI debit. The drag over a 20-year hold typically exceeds the tax-deferral benefit. The 2008 lesson: VUL cash values cratered, forcing premium top-ups or letting policies lapse with the death benefit gone. Skip.